Winston & Strawn LLP Represents Connecticut Pharmaceutical Solutions, Inc.

Winston & Strawn LLP represented Connecticut Pharmaceutical Solutions, Inc., a portfolio company of Tuatara Capital, L.P in its sale to Verano Holdings Corp., a leading multi-state cannabis company. Connecticut Pharmaceutical Solutions owns an operating cultivation and production facility in Rocky Hill, CT. The transaction to acquire 100% of the equity interests in Connecticut Pharmaceutical Solutions, Inc., includes an active, 216,532 sq. ft. state-of-the-art cultivation and production facility in Rocky Hill, Connecticut. Aggregate proceeds for the transaction include US$113,250,000 in subordinate voting shares of the Company upon the consummation of the transaction, US$18,500,000 in subordinate voting shares of the Company upon the first adult-use sale of cannabis in Connecticut, and additional subordinate voting shares based on achieving 2021 EBITDA performance milestones. The agreement was signed on November 10, 2021.

Press Release: https://www.globenewswire.com/news-release/2021/11/10/2331665/0/en/Verano-Enters-Connecticut-Cannabis-Market-with-Vertical-Integration-Ahead-of-Adult-Use-Transition.html

Winston Team:

•            Vaiana, Brad, Lead Partner, New York

•            Gann, Kyle, Lead Partner, Chicago

•            Heller, Rob, Partner, New York

•            Kaufman, Eric, Associate, New York

•            Lanza, Adam, Associate, New York